This inventor holds 2 USPTO granted patents. Top assignee: Eisai Chemical Co., Ltd.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Hirofumi Kuroda: Innovator in Cephem Compound Production
Introduction
Hirofumi Kuroda is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the production of cephem compounds. With a total of 2 patents to his name, Kuroda's work has implications for the development of antibiotics and other pharmaceuticals.
Latest Patents
Kuroda's latest patents include a novel process for producing cephem compounds in an aqueous medium. This innovative method is designed to create compounds that are useful as medicines, especially antibiotics. The process involves reacting a 3-cephem-4-carboxylate with an acid chloride in water, leading to the production of high-quality cephem compounds. Additionally, he has developed a purification method for crude products using column chromatography. This method employs methanol-containing n-hexane as an eluent, allowing for the efficient separation and purification of the intended product with high purity and yield.
Career Highlights
Hirofumi Kuroda is associated with Eisai Chemical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical chemistry. His innovative approaches have contributed to the company's reputation for excellence in the field.
Collaborations
Kuroda has collaborated with notable colleagues such as Masahiko Tsujii and Yoshikazu Furusawa. Their combined expertise has further enhanced the research outcomes in their respective projects.
Conclusion
Hirofumi Kuroda's contributions to the field of medicinal chemistry, particularly in the production and purification of cephem compounds, highlight his role as a significant inventor. His work continues to influence the development of effective antibiotics and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile